These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8341590)

  • 1. Activation of the cryptic DNA binding function of mutant forms of p53.
    Hupp TR; Meek DW; Midgley CA; Lane DP
    Nucleic Acids Res; 1993 Jul; 21(14):3167-74. PubMed ID: 8341590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases.
    Hupp TR; Lane DP
    Cold Spring Harb Symp Quant Biol; 1994; 59():195-206. PubMed ID: 7587070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric activation of latent p53 tetramers.
    Hupp TR; Lane DP
    Curr Biol; 1994 Oct; 4(10):865-75. PubMed ID: 7850419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the specific DNA binding function of p53.
    Hupp TR; Meek DW; Midgley CA; Lane DP
    Cell; 1992 Nov; 71(5):875-86. PubMed ID: 1423635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
    Rolley N; Milner J
    Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
    Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
    Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
    Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
    Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases.
    Takenaka I; Morin F; Seizinger BR; Kley N
    J Biol Chem; 1995 Mar; 270(10):5405-11. PubMed ID: 7534296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner.
    Hupp TR; Lane DP
    J Biol Chem; 1995 Jul; 270(30):18165-74. PubMed ID: 7629129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise characterisation of monoclonal antibodies to the C-terminal region of p53 protein using the PEPSCAN ELISA technique and a new non-radioactive gel shift assay.
    Pospísilová S; Brázda V; Amrichová J; Kamermeierová R; Palecek E; Vojtesek B
    J Immunol Methods; 2000 Apr; 237(1-2):51-64. PubMed ID: 10725451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential.
    Mundt M; Hupp T; Fritsche M; Merkle C; Hansen S; Lane D; Groner B
    Oncogene; 1997 Jul; 15(2):237-44. PubMed ID: 9244359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of casein kinase II with immunopurified p53.
    Herrmann CP; Kraiss S; Montenarh M
    Oncogene; 1991 May; 6(5):877-84. PubMed ID: 2052362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
    Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
    Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
    J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of two distinct COOH-terminal domains is required for murine p53 activation by bacterial Hsp70.
    Hansen S; Midgley CA; Lane DP; Freeman BC; Morimoto RI; Hupp TR
    J Biol Chem; 1996 Nov; 271(48):30922-8. PubMed ID: 8940078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group.
    Hansen S; Hupp TR; Lane DP
    J Biol Chem; 1996 Feb; 271(7):3917-24. PubMed ID: 8632013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human p53 phosphorylation mimic, S392E, increases nonspecific DNA affinity and thermal stability.
    Nichols NM; Matthews KS
    Biochemistry; 2002 Jan; 41(1):170-8. PubMed ID: 11772014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.